Australia Wearable Injectors Market Size & Outlook
Australia wearable injectors market, 2018-2030 (US$M)
Related Markets
Australia wearable injectors market highlights
- The Australia wearable injectors market generated a revenue of USD 223.9 million in 2023 and is expected to reach USD 610.5 million by 2030.
- The Australia market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, on-body was the largest revenue generating type in 2023.
- Off-body is the most lucrative type segment registering the fastest growth during the forecast period.
Wearable injectors market data book summary
| Market revenue in 2023 | USD 223.9 million |
| Market revenue in 2030 | USD 610.5 million |
| Growth rate | 15.4% (CAGR from 2023 to 2030) |
| Largest segment | On-body |
| Fastest growing segment | Off-body |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | On-body, Off-body |
| Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
Other key industry trends
- In terms of revenue, Australia accounted for 2.5% of the global wearable injectors market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China wearable injectors market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 308.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wearable Injectors Market Scope
Wearable Injectors Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia wearable injectors market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 55.52% in 2023. Horizon Databook has segmented the Australia wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
The market for wearable injectors in Australia is growing at a considerable rate. This can be attributed to improvements in cutting-edge technology, a larger patient base, and weak regulatory standards. The prevalence of chronic diseases and rapidly aging population are two additional important factors driving market expansion.
The Department of Health of the Australian government reported in September 2021 that 27% of all fatalities in Australia are caused by cardiovascular illnesses. One or more heart or vascular illnesses affect about 1.2 million Australians.
Reasons to subscribe to Australia wearable injectors market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia wearable injectors market databook
-
Our clientele includes a mix of wearable injectors market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia wearable injectors market , including forecasts for subscribers. This country databook contains high-level insights into Australia wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia wearable injectors market size, by type, 2018-2030 (US$M)
Australia Wearable Injectors Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
